$0.33
-0.01 (-2.31%)
Open$0.34
Previous Close$0.34
Day High$0.37
Day Low$0.32
52W High$14.39
52W Low$0.26
Volume—
Avg Volume1.01M
Market Cap67.15M
P/E Ratio—
EPS$-0.28
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 638.91M | 840.34M | 106.35M |
| Net Income | -36,736,801 | -43,486,940 | 12.42M |
| Profit Margin | -5.8% | -5.5% | 11.7% |
| EBITDA | 17.15M | 21.42M | 22.69M |
| Free Cash Flow | — | — | 8.29M |
| Rev Growth | -24.0% | -24.0% | +7.5% |
| Debt/Equity | — | — | 0.19 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,117.26 | +0.92% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $241.00 | +0.80% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $120.60 | +0.84% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.04 | -2.75% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.00 | -0.95% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $78.17 | +1.73% | 12.5 | 33.00B |